FDA grants fast track designation to glutaminase inhibitor CB-839 in combination with cabozantinib for metastatic kidney cancer
Calithera Biosciences announced earlier this week that the US Food [...]
New ‘fast track’ plans will help to bring promising drugs to the NHS up to 4 years sooner
The Telegraph has reported on comments made by Jeremy Hunt MP, [...]
